IBNSINA logo

The IBN SINA Pharmaceutical Industry PLC Stock Price

DSE:IBNSINA Community·৳9.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 34 Fair Values set on narratives written by author

IBNSINA Share Price Performance

৳317.80
27.40 (9.44%)
৳317.80
27.40 (9.44%)
Price ৳317.80

IBNSINA Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Proven track record average dividend payer.

4 Risks
2 Rewards

The IBN SINA Pharmaceutical Industry PLC Key Details

৳13.4b

Revenue

৳8.0b

Cost of Revenue

৳5.5b

Gross Profit

৳4.6b

Other Expenses

৳815.7m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
26.11
40.67%
6.08%
66.0%
View Full Analysis

About IBNSINA

Founded
1983
Employees
5200
CEO
A. K. Sadrul Islam
WebsiteView website
www.ibnsinapharma.com

The IBN SINA Pharmaceutical Industry PLC produces and sells pharmaceutical drugs in Bangladesh and internationally. The company provides its products in various forms, such as solid dosage forms consisting of tablets and capsules; parenteral products covering ampoules and vials; liquid dosage forms comprising syrups, solutions, suspensions, and powder for suspension (dry syrups); and sterile ophthalmic products, creams, ointments, gels, eye drops and sachet, etc. It also offers various therapeutic products, including analgesic and anti-inflammatory, anti-dementia, anti-heamorrhoidal, anti-allergic-occular, anti-arthritis supplement, anti-asthmatic, anti-emetic, anti-fibrinolytic, anti-fungal, anti-glucoma, anti-histamine, anti-malarial, anti-melasma, anti-neuropathic, anti-protozoal, anti-spasmodic, anti-ulcerant, antibacterial, antibiotic, anticataract, anti-diabetic, anti-helmintic, antimigraine agent, antivertigo agent, and antiviral products. In addition, the company’s therapeutic products comprise antibiotic and steroid, gastrointestinal and skin diseas, antibiotic-occular, antifungal-occular, antiviral-occular, anxiolytic and antidepressant, aromatase inhibitor, bile acid, bisphosphonates, calcium supplement, cardiovascular preparation, corticosteroid, cough expectorant, dry eye syndrome, gastroprokinetic agent, haematinic/vitamin and mineral, hand rub, hormone products, intestinal anti-inflammatory, laxative, multivitamin and multi-minerals, muscle relaxant, mydriatic agents, nootropic, ORS, topical, urological preparation products. Further, it provides herbal and Unani products; and manufactures and trades in active pharmaceutical ingredients, natural medicines, polymer plastic bottles, plastic tubes, laminated tubes, and other related products. The company was incorporated in 1983 and is headquartered in Dhaka, Bangladesh.

Recent IBNSINA News & Updates

Recent updates

No updates